 The approval of one short Sputnik-Lite vaccine in India is definitely a very important milestone in the world's fight against the pandemic. So now more than 30 countries with a population of more than 2.5 billion people registered Sputnik-Lite vaccine. And it's really a Russian Indian vaccine because Serum Institute, the largest vaccine producer, Hetero and many other Indian producers are producing Sputnik-Lite vaccine now. And the vaccine is incredibly efficient against Omicron, which has been shown by an independent study in the Italy Spallanzani Institute, which showed Sputnik-V and Sputnik-Lite are some of the most efficient vaccines in the world against Omicron. And what's very important that can be stored at plus two, plus eight degree temperature for a very long time, making it a really viable solution, not only as a standalone vaccine, but also as a universal booster for other vaccines in many countries. So we are very happy with our cooperation with the Indian regulator, Indian government. This is the result of long studies in Russia, in Argentina, in India and many countries of Sputnik-Lite vaccine, which has shown to be one of the most efficient vaccine against Omicron. Very important going forward that Sputnik-Lite demonstrated great results as part of the mix and match approach with other vaccines, really boosting and lengthening the immune response. We showed this with study with AstraZeneca, with study of mix and match approach with many vaccines in Argentina. So this Sputnik-Lite going forward is going to be a very important part of the fight against the pandemic as a universal booster for many other vaccines, lengthening and strengthening the response against Omicron and other mutations.